CRISPR cancer trial finds that gene-edited immune cells are safe

Three people with advanced tumours received a dose of CRISPR gene-edited immune cells and had no serious side effects, paving the way for more trials using this technique
Source: New Scientist - Health - Category: Consumer Health News Source Type: research